Abstract |
A series of novel, multisubstrate, bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase (TP) is described. Thymidine phosphorylase has been implicated in angiogenesis and plays a significant role in tumor progression and metastasis. The presence and orientation of the phosphonate moiety (acting as a phosphate mimic) in these derivatives were critical for inhibitory activity. The most active compounds possessed a phosphonate group in an endo orientation. This was consistent with molecular modeling results that showed the endo isomer protein- ligand complex to be lower in energy than the exo complex.
|
Authors | Amy L Allan, Patricia L Gladstone, Melissa L P Price, Stephanie A Hopkins, Jose C Juarez, Fernando Doñate, Robert J Ternansky, David E Shaw, Bruce Ganem, Yingbo Li, Weiru Wang, Steven Ealick |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 49
Issue 26
Pg. 7807-15
(Dec 28 2006)
ISSN: 0022-2623 [Print] United States |
PMID | 17181163
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Bridged Bicyclo Compounds, Heterocyclic
- Enzyme Inhibitors
- Pyrimidine Nucleosides
- Thymidine Phosphorylase
|
Topics |
- Bridged Bicyclo Compounds, Heterocyclic
(chemical synthesis, chemistry, pharmacology)
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Humans
- Models, Molecular
- Molecular Structure
- Pyrimidine Nucleosides
(chemical synthesis, chemistry, pharmacology)
- Structure-Activity Relationship
- Thymidine Phosphorylase
(antagonists & inhibitors)
|